Patients With IBD at Increased Risk for CVD, Renal Complications After COVID-19
Infection with SARS-CoV-2 has been associated with increased risk for CVD and renal complications.
All articles by Jessica Nye, PhD
An Inhaled IFN-ß Treatment May Decrease Risk for Long COVID-19 Symptoms
Patients with COVID-19 who required low-flow oxygen supplementation were randomly assigned to receive either SNG001 (n=314) or placebo (n=309) once daily for 14 days.
Monkeypox MVA-BN Vaccine Elicits Durable Immunity for 2 Years With Single Dose
The MVA-BN vaccine, developed by Bavarian Nordic, was evaluated in a clinical trial.
Upadacitinib Induction Therapy Shows Favorable Outcomes in Moderate to Severe Crohn Disease
The patient cohorts were well-balanced at baseline, and, overall, 45.4% had a history of biologic therapy failure.
Ustekinumab Concentrations Linked to Crohn Disease Radiologic, Biomarker Outcomes
Although ustekinumab is a common therapy used to treat CD, no serum concentrations that associate with outcomes have been established.
Endoscopic Sleeve Gastroplasty Safe and Efficacious for Class III Obesity
The study authors concluded that ESG is safe for patients with class III obesity and its efficacy was comparable to SG and RNYB.
Novel Immunoassay Stratifies Between Bacterial, Viral Infections in Children
Researchers evaluated the accuracy of the BV score using data from pediatric patients with fever who presented at emergency departments or urgent care centers.
Prediabetes Associated With Increased Long-Term Colorectal Cancer Risk
The pooled cohort comprised 854,876 prediabetes cases and 2,190,511 control cases.
Oral Capsule Effective as Fecal Microbiota Transplant Delivery Strategy
Rate of decolonization was highest for patients in the EGD group (85.7%), followed by those in the oral capsule (84.6%), colonoscopy (63.6%), and gastric tube (50%) groups.
Subcutaneous Lenacapavir Effective for Patients With Multidrug-Resistant HIV
During a median follow-up period of 73 (range, 13-111) weeks, 1 patient discontinued treatment with lenacapavir due to grade 1 nodule at the injection site.
